Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Accenture
Chubb
Farmers Insurance
Fuji
Johnson and Johnson
US Department of Justice
Merck
Medtronic
Queensland Health

Generated: October 22, 2017

DrugPatentWatch Database Preview

OMEGA-3-ACID ETHYL ESTERS Drug Profile

« Back to Dashboard

Which patents cover Omega-3-acid Ethyl Esters, and when can generic versions of Omega-3-acid Ethyl Esters launch?

Omega-3-acid Ethyl Esters is a drug marketed by Par Pharm Inc, Teva Pharms Usa, Amneal Pharms, Apotex Inc, and Strides Pharma. and is included in five NDAs.

The generic ingredient in OMEGA-3-ACID ETHYL ESTERS is omega-3-acid ethyl esters. There are thirteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the omega-3-acid ethyl esters profile page.

Summary for Tradename: OMEGA-3-ACID ETHYL ESTERS

US Patents:0
Applicants:5
NDAs:5
Suppliers / Packagers: see list16
Clinical Trials: see list5,129
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OMEGA-3-ACID ETHYL ESTERS at DailyMed

Pharmacology for Tradename: OMEGA-3-ACID ETHYL ESTERS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm Inc
OMEGA-3-ACID ETHYL ESTERS
omega-3-acid ethyl esters
CAPSULE;ORAL091018-001Jun 24, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
OMEGA-3-ACID ETHYL ESTERS
omega-3-acid ethyl esters
CAPSULE;ORAL090973-001Sep 30, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
OMEGA-3-ACID ETHYL ESTERS
omega-3-acid ethyl esters
CAPSULE;ORAL091028-001Apr 7, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
OMEGA-3-ACID ETHYL ESTERS
omega-3-acid ethyl esters
CAPSULE;ORAL204940-001Nov 27, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Strides Pharma
OMEGA-3-ACID ETHYL ESTERS
omega-3-acid ethyl esters
CAPSULE;ORAL203893-001Sep 19, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Argus Health
Baxter
Johnson and Johnson
Cipla
Accenture
UBS
Chinese Patent Office
Merck
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot